Safety concerns raised for neuroblastoma candidate drug
St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Then researchers identified safety concerns with the experimental drug that have implications for current clinical trials in adults. The study appears today in Nature Communications.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: Brain | Child Development | Children | Clinical Trials | Hospitals | Neuroblastoma | Neurology | Pharmaceuticals | Study